Search Results - "Vaile, John"

Quadrivalent influenza nanoparticle vaccines induce broad protection by Boyoglu-Barnum, Seyhan, Ellis, Daniel, Gillespie, Rebecca A., Hutchinson, Geoffrey B., Park, Young-Jun, Moin, Syed M., Acton, Oliver J., Ravichandran, Rashmi, Murphy, Mike, Pettie, Deleah, Matheson, Nick, Carter, Lauren, Creanga, Adrian, Watson, Michael J., Kephart, Sally, Ataca, Sila, Vaile, John R., Ueda, George, Crank, Michelle C., Stewart, Lance, Lee, Kelly K., Guttman, Miklos, Baker, David, Mascola, John R., Veesler, David, Graham, Barney S., King, Neil P., Kanekiyo, Masaru

“…Influenza vaccines that confer broad and durable protection against diverse viral strains would have a major effect on global health, as they would lessen the…”
Get full text

Asthma Prevalence among Athletes in an Urban Adolescent Population by Siegel, Charles, Tecce, Eric, Vaile, John R., Maheu, Arlene, Close, Jeremy

“…Objective: To identify individuals at risk of asthma by assessing the prevalence of asthma in an urban, athletic adolescent population using preparticipation…”
Get full text

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses by Boyoglu-Barnum, Seyhan, Hutchinson, Geoffrey B., Boyington, Jeffrey C., Moin, Syed M., Gillespie, Rebecca A., Tsybovsky, Yaroslav, Stephens, Tyler, Vaile, John R., Lederhofer, Julia, Corbett, Kizzmekia S., Fisher, Brian E., Yassine, Hadi M., Andrews, Sarah F., Crank, Michelle C., McDermott, Adrian B., Mascola, John R., Graham, Barney S., Kanekiyo, Masaru

“…The conserved hemagglutinin (HA) stem has been a focus of universal influenza vaccine efforts. Influenza A group 1 HA stem-nanoparticles have been demonstrated…”
Get full text

Streamlining Iliac Bone Harvest for Maxillary Reconstruction With Novel Use of Arthrex Osteochondral Autograft Transfer System by Isch, Emily L, Vaile, John R, Rosado, Jose A, Caterson, Edward J

“…This study introduces a novel application of the Osteochondral Autograft Transfer System (OATS) for autologous bone grafting during alveolar cleft repair…”
Get full text

Prior Meniscectomy in Patients Undergoing Primary Total Knee Arthroplasty is Associated With Worse Short-Term Outcomes by Khan, Irfan A., DeSimone, Cristian A., Sonnier, John Hayden, Vaile, John R., Mazur, Donald W., Freedman, Kevin B., Fillingham, Yale A.

“…Patients undergoing total knee arthroplasty (TKA) who have prior meniscectomy may have increased rates of postoperative infection, arthrofibrosis, and…”
Get full text

Undergoing Meniscectomy Within One Year Before Primary Total Knee Arthroplasty Is Associated With Worse Postoperative Outcomes by Khan, Irfan A., DeSimone, Cristian A., Vaile, John R., Sonnier, John Hayden, Sherman, Matthew B., Mazur, Donald W., Freedman, Kevin B., Fillingham, Yale A.

“…Patients undergoing primary total knee arthroplasty (TKA) who have a history of meniscectomy have worse postoperative functional outcomes, increased rates of…”
Get full text

Image-Free Robotic-Assisted Total Knee Arthroplasty Results in Quicker Recovery but Equivalent One-Year Outcomes Compared to Conventional Total Knee Arthroplasty by Khan, Irfan A., Vaile, John R., DeSimone, Cristian A., Parsell, Douglas E., Heinze, Jared D., Alessi, Alexandra, Xu, Winnie, Shah, Roshan P., Pickering, Trevor, Cafferky, Nathan L., Lonner, Jess H.

“…Few studies have addressed whether robotic-assisted total knee arthroplasty (RA-TKA) significantly impacts functional outcomes. This study was conducted to…”
Get full text

The effects of a multidisciplinary pathway for perioperative management of patients with hip fracture by Ackermann, Lily L., Schwenk, Eric S., Li, Chris J., Vaile, John R., Weitz, Howard

“…OBJECTIVESTo determine if a multidisciplinary pathway focused on non-opioid pain management, delirium assessment, and resource utilization improved outcomes in…”
Get full text

Analgesic options for anterior approach to scoliosis repair: a scoping review by Li, Chris J, Vaile, John R, Gal, Jonathan S, Park, Chang H, Burnett, Garrett W

“…The ideal analgesic regimen for the anterior approach to scoliosis repair is not clearly defined. The purpose of the study was to summarize and identify gaps…”
Get more information

Recent Advancements and Outcomes of Syndactyly and Polydactyly, Experience from over 2300 Cases by Mendenhall, Shaun, Struble, Sarah, Vaile, John, Patel, Niki, Graham, Emily, Chang, Benjamin

Get full text

Outcomes of Biodegradable Temporizing Matrix for Soft Tissue Reconstruction of the Hand and Extremities by Struble, Sarah L, Patel, Niki K, Graham, Emily M, Tipps, John A, Vaile, John R, Leeflang, Elisabeth J, Goodwin, Isak, Mendenhall, Shaun D

“…NovoSorb biodegradable temporizing matrix (BTM) is a novel, bilayer, synthetic skin substitute made of biodegradable polyurethane foam covered with a sealing…”
Get full text

Improving Skin Paddle Reliability and Muscle Gliding in Free Functional Gracilis Transfers by Vaile, John R, Struble, Sarah L, Patel, Niki K, Janes, Lindsay E, Park, Eugene D, Levin, L Scott, Mendenhall, Shaun D

“…Free functional muscle transfer is an attractive option within reconstructive surgery when seeking to restore critical muscle function. The gracilis muscle has…”
Get full text

Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials by Michaud, Kaleb, Conaghan, Philip G., Park, Sang Hee, Lozenski, Karissa, Fillbrunn, Mirko, Khaychuk, Vadim, Swallow, Elyse, Vaile, John, Lane, Henry, Nguyen, Ha, Pope, Janet

“…Introduction The efficacy of abatacept is enhanced in anti-citrullinated protein antibody (ACPA) and rheumatoid factor (RF)-positive versus -negative patients…”
Get full text

87. Cost Effectiveness Of Postaxial Polydactyly Type B Excision In The Office Vs. Operating Room by Banala, Manisha, Struble, Sarah L., Chang, Benjamin, Shah, Apurva S., Buttrick, Eliza, Cordray, Holly, Vaile, John R., Mendenhall, Shaun D.

Get full text

Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS by Ungaro, Ryan C., Siegel, Corey A., Cree, Bruce, Selmaj, Krzysztof, Ahmad, Harris, Pai, Ashwini, Ather, Shabana, Henry, Alyssa, Charles, Lorna, Petersen, AnnKatrin, Cheng, Chun-Yen, Afsari, Sonia, Sheffield, James K., Vaile, John, Colombel, Jean Frederic

Get full text

Evaluating No Evidence of Disease Activity in Patients With Relapsing Multiple Sclerosis: Post Hoc Analysis of the Phase 3 RADIANCE and Open-Label Extension Studies of Ozanimod (P7-4.012) by Kappos, Ludwig, Comi, Giancarlo, Selmaj, Krzysztof, Steinman, Lawrence, Bar-Or, Amit, Arnold, Douglas, Hartung, Hans-Peter, Montalbán, Xavier, Havrdová, Eva, Pachai, Chahin, Sheffield, James, Cheng, Chun-Yen, Silva, Diego, Vaile, John, Morello, Jean Pierre, Cohen, Jeffrey, Cree, Bruce

“…Abstract only…”
Get full text

Deucravacitinib in Plaque Psoriasis: 4-year Safety and Efficacy Results from the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials by Armstrong, April W., Lebwohl, Mark, Warren, Richard B., Sofen, Howard, Morita, Akimichi, Imafuku, Shinichi, Ohtsuki, Mamitaro, Spelman, Lynda, Passeron, Thierry, Papp, Kim A., Colombo, Matthew J., Vaile, John, Vritzali, Eleni, Hoyt, Kim, Daamen, Carolin, Banerjee, Subhashis, Strober, Bruce, Thaçi, Diamant, Blauvelt, Andrew

“…Introduction: Deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, is approved in multiple countries for treatment of adults with moderate to severe…”
Get full text

3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement by Vaile, John R., Rame, J. Eduardo, Alvarez, Rene J., Massey, Howard T., Tchantchaleishvili, Vakhtang, Vishnevsky, Alec, Rajapreyar, Indranee N., Brailovsky, Yevgeniy, Shah, Mahek K.

“…We present 3 cases of superior vena cava (SVC) syndrome following percutaneous right ventricular assist device (RVAD) placement. Each case underscores the…”
Get full text

Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials by Armstrong, April W., Lebwohl, Mark, Warren, Richard B., Sofen, Howard, Morita, Akimchi, Imafuku, Shinichi, Ohtsuki, Mamitaro, Spelman, Lynda, Passeron, Thierry, Papp, Kim A., Colombo, Matthew J., Vaile, John, Vritzali, Eleni, Hoyt, Kim, Daamen, Carolin, Banerjee, Subhashis, Strober, Bruce, Thaçi, Diamant, Blauvelt, Andrew

“…Introduction: Deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, is approved in the US, EU, and other countries for treatment of adults with…”
Get full text

2221 Evaluating no evidence of disease activity (NEDA) with Ozanimod in patients with relapsing multiple sclerosis (RMS): post hoc analysis of phase 3 RADIANCE and DAYBREAK by Kappos, Ludwig, Comi, Giancarlo, Selmaj, Krzysztof W, Steinman, Lawrence, Bar-Or, Amit, Arnold, Douglas L, Hartung, Hans-Peter, Montalbán, Xavier, Havrdová, Eva K, Pachai, Chahin, Sheffield, James K, Cheng, Chun-Yen, Silva, Diego, Vaile, John, Morello, Jean Pierre, Cohen, Jeffrey A, Guevara-Harrison, Narelle, Cree, Bruce AC

“…ObjectiveTo assess NEDA-3 and NEDA-4 in RMS patients treated with ozanimod.MethodsData are from a randomized phase 3 trial (RADIANCE-NCT02047734) of oral…”
Get full text